Eurocapital Corp said its&lt;Europharmaceutical Corp> affiliate has submitted fourapplications to the U.S. Food and Drug Administration forapproval to market in the U.S. three condom products to be madeby &lt;Inkey SA> of Barcelona.    The company said one is for approval to market a condomcontaining spermicide monoxynol-9, a second for the same condomwithout the spermicide and the third and fourth for marketingof a condom with a diffierent spermicide it did not identifythat is said is effective in reducing the risk of sexualtransmission of the AIDS virus.    The company said  the approval process on the last twoapplications may be lengthy.    It also said it has increased its ownership ofEuropharmaceutical to 51 pct from 45 pct.    It said Europharmaceutical's obligation to pay Inkey forexclusive distribution rights to all Inkey products has beencut to 500,000 dlrs from two mln dlrs and payment has beenextended to 180 days after FDA approval to market any of thecondom products from 30 days.  It said Europharmaceutical isnow obligated to pay Inkey two cts for each condom distributedand Inkey will ship to Europharmaceutical on open account. Reuter&#3;